Nelson, Van Denburg & Campbell Wealth Management Group, LLC Akero Therapeutics, Inc. Call Options Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.53 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
209Shares Held
67.5MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$264 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$232 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$215 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$202 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$166 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.79B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...